drugset / Trial / NCT01441752

Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

NCT01441752 ↗

Phase 3 Completed 349 enrolled xuling
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators performed a multi-center, randomized, controlled, double-blind, prospective study on evaluating effect of chemotherapy combined with or without integrated TCM on quality of life (QOL) of postoperative Non-small Cell Lung Cancer (NSCLC) patients. The investigators plan to involve 600 cases for observation in 3 years (300 cases for each group), expecting that QOL of postoperative NSCLC patients can be improved by integrated TCM combined with chemotherapy compared to that by chemotherapy alone.

Timeline

Start
2011-11
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject TCM Traditional medicine (herbal / TCM) 20 g Oral